Endothelial–Pericyte Interactions Regulate Angiogenesis Via VEGFR2 Signaling During Retinal Development and Disease
Investigative Ophthalmology & Visual Science · 2025-09-19 · 66 (12) · 45
DOI: 10.1167/iovs.66.12.45 ↗At a glance
Journal article in Investigative Ophthalmology & Visual Science, published on 2025-09-19. Written by Ying-Yu Lin and 4 co-authors. Institution: Department of Biomedical Engineering, Duke University, Durham, North Carolina, United States. Major MEDLINE topics: Vascular Endothelial Growth Factor Receptor-2, Pericytes, Retinal Neovascularization, Endothelial Cells. Cited 12 times so far (Crossref); 84 references. The full text is freely available (open access, CC BY-NC-ND 4.0). Funded by: NHLBI NIH HHS, NCI NIH HHS, NEI NIH HHS.
Abstract (original language)
Purpose
Endothelial-pericyte interaction disruption causes vascular dropout and pathological angiogenesis, severely impacting visual function in ocular microvascular diseases. This study examines VEGF receptor 2 (VEGFR2) signaling in endothelial-pericyte interactions, highlighting VEGFR2 as a potential therapeutic target for promoting pericyte coverage and decreasing vascular leakage in diseased retinas.
Method
Cell-cell interactions with VEGFR2 signaling were assessed using isogenic endothelial cells and pericytes from induced pluripotent stem cells. We investigated changes in VEGFR2 signaling resulting from endothelial-pericyte interactions using quantitative Reverse Transcription PCR, western blot analysis, immunofluorescence staining, migration assays, permeability assays, transendothelial electrical resistance measurements, flow cytometry, and three-dimensional collagen gel vascular networks. We validated VEGFR2 as a therapeutic target via intravitreal injection in the oxygen-induced retinopathy mouse model. Treatment effects were evaluated using western blot analysis, immunofluorescence staining, and an FITC-dextran permeability assay to assess protein expression, pericyte recruitment, and retinal vascular function in response to VEGFR2 modulation.
Results
We demonstrate that direct endothelial-pericyte contact, mediated by N-cadherin, downregulates phosphorylated VEGFR2 in endothelial cells, thereby enhancing pericyte migration and promoting endothelial cell barrier function. Intravitreal injection of a VEGFR2 inhibitor in mouse models of the developing retina and oxygen-induced retinopathy increased pericyte recruitment and decreased vascular leakage. The VEGFR2 inhibitor further rescued ischemic retinopathy by enhancing vascularization and tissue growth.
Conclusions
Our findings uncover a novel mechanism by which VEGFR2 signaling is regulated through endothelial-pericyte interactions, promoting pericyte migration and strengthening endothelial barrier function. These results suggest a pathway that could be harnessed to support the growth of functional and mature microvasculature in ocular microvascular diseases and tissue regeneration overall.
Subjects
MeSH terms (MEDLINE)
Substances
Authors and institutions
- Department of Biomedical Engineering, Duke University, Durham, North Carolina, United States.
- Department of Chemical and Biomolecular Engineering, Johns Hopkins University, Baltimore, Maryland, United States.
Funding
- NHLBI NIH HHS
- NCI NIH HHS
- NEI NIH HHS
Cite
APA
Lin, Y. Y., Warren, E., Macklin, B. L., Ramirez, L., & Gerecht, S. (2025). Endothelial–Pericyte Interactions Regulate Angiogenesis Via VEGFR2 Signaling During Retinal Development and Disease. Investigative Ophthalmology & Visual Science, 66(12), 45. https://doi.org/10.1167/iovs.66.12.45
Vancouver
Lin YY, Warren E, Macklin BL, Ramirez L, Gerecht S. Endothelial–Pericyte Interactions Regulate Angiogenesis Via VEGFR2 Signaling During Retinal Development and Disease. Investigative Ophthalmology & Visual Science. 2025;66(12):45. doi:10.1167/iovs.66.12.45
BibTeX
@article{Lin2025,
author = {Lin, Ying-Yu and Warren, Emily and Macklin, Bria L and Ramirez, Lucas and Gerecht, Sharon},
title = {Endothelial–Pericyte Interactions Regulate Angiogenesis Via VEGFR2 Signaling During Retinal Development and Disease},
journal = {Investigative Ophthalmology & Visual Science},
year = {2025},
volume = {66},
number = {12},
pages = {45},
doi = {10.1167/iovs.66.12.45}
}
EUVIMED